Community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections;Les infections à Staphylococcus aureus résistant à la méticilline (SARM) d'acquisition communautaire

Medecine et Maladies Infectieuses

Volumn 41, Issue 4, 2011, Pages 167-175

  Tattevin, P ^a,b,c  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Community acquired infection; MRSA; Panton Valentine leukocidin (PVL); SCCmec type IV; Staphylococcus aureus

Indexed keywords

PANTON VALENTINE LEUKOCIDIN;

AUSTRALIA; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; COMMUNICABLE DISEASE; DISEASE SURVEILLANCE; EUROPE; GENE CASSETTE; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; IMMUNOCOMPETENCE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR CLONING; NONHUMAN; NORTH AMERICA; REVIEW;

AUSTRALIA; BACTERIAL TOXINS; CHROMOSOMES, BACTERIAL; CLONE CELLS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EUROPE; EXOTOXINS; GENOMIC ISLANDS; HUMANS; LEUKOCIDINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; NORTH AMERICA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS PHAGES; VIRULENCE; WORLD HEALTH;

EID: 79954611102     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2010.11.017     Document Type: Review

References (60)

1. Kluytmans J., van Belkum A., Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997, 10(3):505-520.
2. Miller L.G., Diep B.A. Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008, 46(5):752-760.
3. Diep B.A., Otto M. The role of virulence determinants in community-associated MRSA pathogenesis. Trends Microbiol 2008, 16(8):361-369.
4. Chambers H.F. Community-associated MRSA--resistance and virulence converge. N Engl J Med 2005, 352(14):1485-1487.
5. Lowy F.D. Staphylococcus aureus infections. N Engl J Med 1998, 339(8):520-532.
6. Parsonnet J., Deresiewicz R.L. Staphylococcal infections. Harrison's principles of internal medicine 2001, 889-901. McGraw-Hill. E. Brauwald, A.S. Fauci, D.L. Kasper (Eds.).
7. Lowy F.D. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 2003, 111(9):1265-1273.
8. Kirby W.M. Extraction of a highly potent penicillin inactivator from penicillin resistant staphylococci. Science 1944, 99(2579):452-453.
9. Tenover F.C. Mechanisms of antimicrobial resistance in bacteria. Am J Med 2006, 119(6 Suppl. 1):S3-S10. [discussion S62-70].
10. Katayama Y., Ito T., Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2000, 44(6):1549-1555.
11. Stryjewski M.E., Szczech L.A., Benjamin D.K., et al. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 2007, 44(2):190-196.
12. Cosgrove S.E., Qi Y., Kaye K.S., Harbarth S., Karchmer A.W., Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005, 26(2):166-174.
13. Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaber M.J., Karchmer A.W., Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003, 36(1):53-59.
14. Cosgrove S.E. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006, 42(Suppl. 2):S82-S89.
15. Saravolatz L.D., Markowitz N., Arking L., Pohlod D., Fisher E. Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak. Ann Intern Med 1982, 96(1):11-16.
16. Saravolatz L.D., Pohlod D.J., Arking L.M. Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks. Ann Intern Med 1982, 97(3):325-329.
17. Udo E.E., Pearman J.W., Grubb W.B. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect 1993, 25(2):97-108.
18. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus--Minnesota and North Dakota, 1997-1999. JAMA 1999, 282(12):1123-1125. From the Centers for Disease Control and Prevention.
19. Herold B.C., Immergluck L.C., Maranan M.C., et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998, 279(8):593-598.
20. McDougal L.K., Steward C.D., Killgore G.E., Chaitram J.M., McAllister S.K., Tenover F.C. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003, 41(11):5113-5120.
21. Pan E.S., Diep B.A., Charlebois E.D., et al. Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus--and their relation to community-associated disease activity. J Infect Dis 2005, 192(5):811-818.
22. Moran G.J., Krishnadasan A., Gorwitz R.J., et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006, 355(7):666-674.
23. King M.D., Humphrey B.J., Wang Y.F., Kourbatova E.V., Ray S.M., Blumberg H.M. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 2006, 144(5):309-317.
24. Diep B.A., Sensabaugh G.F., Somboona N.S., Carleton H.A., Perdreau-Remington F. Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin. J Clin Microbiol 2004, 42(5):2080-2084.
25. Rubinstein E., Kollef M.H., Nathwani D. Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008, 46(Suppl. 5):S378-S385.
26. Gillet Y., Issartel B., Vanhems P., et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002, 359(9308):753-759.
27. Gillet Y., Vanhems P., Lina G., et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis 2007, 45(3):315-321.
28. Garnier F., Tristan A., Francois B., et al. Pneumonia and new methicillin-resistant Staphylococcus aureus clone. Emerg Infect Dis 2006, 12(3):498-500.
29. Chua T., Moore C.L., Perri M.B., et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates in urban Detroit. J Clin Microbiol 2008, 46(7):2345-2352.
30. Diep B.A., Palazzolo-Ballance A.M., Tattevin P., et al. Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS One 2008, 3(9):e3198.
31. Millar B.C., Prendergast B.D., Moore J.E. Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis. J Antimicrob Chemother 2008, 61(1):1-7.
32. Miller L.G., Perdreau-Remington F., Rieg G., et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005, 352(14):1445-1453.
33. Ruiz M.E., Yohannes S., Wladyka C.G. Pyomyositis caused by methicillin-resistant Staphylococcus aureus. N Engl J Med 2005, 352(14):1488-1489.
34. Fowler A., Mackay A. Community-acquired methicillin-resistant Staphylococcus aureus pyomyositis in an intravenous drug user. J Med Microbiol 2006, 55(Pt 1):123-125.
35. Gelfand M.S., Cleveland K.O., Heck R.K., Goswami R. Pathological fracture in acute osteomyelitis of long bones secondary to community-acquired methicillin-resistant Staphylococcus aureus: two cases and review of the literature. Am J Med Sci 2006, 332(6):357-360.
36. Gillet Y., Dohin B., Dumitrescu O., et al. Osteoarticular infections with Staphylococcus aureus secreting Panton-Valentine leucocidin. Arch Pediatr 2007, 14(Suppl. 2):S102-S107.
37. Kourbatova E.V., Halvosa J.S., King M.D., Ray S.M., White N., Blumberg H.M. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am J Infect Control 2005, 33(7):385-391.
38. Adem P.V., Montgomery C.P., Husain A.N., et al. Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med 2005, 353(12):1245-1251.
39. Rubinstein E. Staphylococcus aureus bacteraemia with known sources. Int J Antimicrob Agents 2008, 32(Suppl 1):S18-S20.
40. Nourse C., Starr M., Munckhof W. Community-acquired methicillin-resistant Staphylococcus aureus causes severe disseminated infection and deep venous thrombosis in children: literature review and recommendations for management. J Paediatr Child Health 2007, 43(10):656-661.
41. Klevens R.M., Morrison M.A., Nadle J., et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298(15):1763-1771.
42. Klevens R.M., Edwards J.R., Tenover F.C., McDonald L.C., Horan T., Gaynes R. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 2006, 42(3):389-391.
43. Seybold U., Kourbatova E.V., Johnson J.G., et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006, 42(5):647-656.
44. Han L.L., McDougal L.K., Gorwitz R.J., et al. High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center. J Clin Microbiol 2007, 45(4):1350-1352.
45. Diep B.A., Chambers H.F., Graber C.J., et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008, 148(4):249-257.
46. Millar B.C., Loughrey A., Elborn J.S., Moore J.E. Proposed definitions of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA). J Hosp Infect 2007, 67(2):109-113.
47. Tattevin P., Diep B.A., Jula M., Perdreau-Remington F. Methicillin-resistant Staphylococcus aureus USA300 clone in long-term care facility. Emerg Infect Dis 2009, 15(6):953-955.
48. Tristan A., Ferry T., Durand G., et al. Virulence determinants in community and hospital meticillin-resistant Staphylococcus aureus. J Hosp Infect 2007, 65(Suppl. 2):105-109.
49. Deurenberg R.H., Vink C., Kalenic S., Friedrich A.W., Bruggeman C.A., Stobberingh E.E. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2007, 13(3):222-235.
50. Lee S.M., Ender M., Adhikari R., Smith J.M., Berger-Bachi B., Cook G.M. Fitness cost of staphylococcal cassette chromosome mec in methicillin-resistant Staphylococcus aureus by way of continuous culture. Antimicrob Agents Chemother 2007, 51(4):1497-1499.
51. Ferry T., Thomas D., Genestier A.L., et al. Comparative prevalence of superantigen genes in Staphylococcus aureus isolates causing sepsis with and without septic shock. Clin Infect Dis 2005, 41(6):771-777.
52. Boyle-Vavra S., Daum R.S. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab Invest 2007, 87(1):3-9.
53. Tristan A., Bes M., Meugnier H., et al. Global distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 2007, 13(4):594-600.
54. Dauwalder O., Lina G., Durand G., et al. Epidemiology of invasive MRSA clones in France, 2006-2007. J Clin Microbiol 2008, 46(10):3454-3458.
55. Robert J., Etienne J., Bertrand X. Methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a retrospective case series from 12 French hospital laboratories, 2000-2003. Clin Microbiol Infect 2005, 11(7):585-587.
56. Kuijper E.J., Barbut F., Brazier J.S., et al. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill 2008, 13(31):1-7.
57. Kajita E., Okano J.T., Bodine E.N., Layne S.P., Blower S. Modelling an outbreak of an emerging pathogen. Nat Rev Microbiol 2007, 5(9):700-709.
58. Hota B., Ellenbogen C., Hayden M.K., Aroutcheva A., Rice T.W., Weinstein R.A. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections at a public hospital: do public housing and incarceration amplify transmission?. Arch Intern Med 2007, 167(10):1026-1033.
59. Tattevin P., Diep B.A., Jula M., Perdreau-Remington F. Long-term follow-up of methicillin-resistant Staphylococcus aureus molecular epidemiology after emergence of clone USA300 in San Francisco jail populations. J Clin Microbiol 2008, 46(12):4056-4057.
60. Diep B.A., Gill S.R., Chang R.F., et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006, 367(9512):731-739.